This nod comes just weeks after the company won approval from China’s National Medical Products Administration for the Genesis robotic magnetic navigation (RNM) system. St. Louis, Missouri-based Stereotaxis aims to accelerate access to its minimally invasive technology in China. In 2021, the company inked a collaboration with MicroPort EP, a Shanghai-based firm, for distribution and commercialization in China.

Magbot is a single-use, magnetic, saline-irrigated radiofrequency (RF) ablation catheter. MicroPort EP designed the system in collaboration with Stereotaxis. The catheter works exclusively and in tight conjunction with Stereotaxis’ robotic systems, including Genesis. It also works with MicroPort EP’s Columbus 3D EP mapping system.